Primary resistance to nivolumab plus ipilimumab therapy affects second-line treatment outcomes in patients with metastatic renal cell carcinoma

Kanami Mori, Kazuyuki Numakura*, Yuto Matsushita, Takahiro Kojima, Takahiro Osawa, Tomokazu Sazuka, Shingo Hatakeyama, Keisuke Goto, Kazutoshi Yamana, Shuya Kandori, Takahiro Kimura, Naotaka Nishiyama, Yukari Bando, Kazutoshi Fujita, Kosuke Ueda, Hajime Tanaka, Ryotaro Tomida, Toshifumi Kurahashi, Hiroshi Kitamura, Hideaki MiyakeTomonori Habuchi

*この論文の責任著者

研究成果: ジャーナルへの寄稿学術論文査読

フィンガープリント

「Primary resistance to nivolumab plus ipilimumab therapy affects second-line treatment outcomes in patients with metastatic renal cell carcinoma」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases